Joseph K. Belanoff
Chief Executive Officer at Corcept Therapeutics. Based in Redwood City, California.
- Rank
- 580th of 14,452
- Companies held
- 1
- Largest holding
- CORT, 100.0% of total
- Latest SEC filing
- Jun 1, 2026
What the $368M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Corcept Therapeutics CORT Common Stock | Indirectly (see filing footnote) | 2,944,524 | $64.98 | $191M | 52.0% | Form 4, Dec 24, 2025 |
| Corcept Therapeutics CORT Common Stock | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 | 2,565,489 | $64.98 | $167M | 45.3% | Form 4, Jun 1, 2026 |
| Corcept Therapeutics CORT Common Stock | Joseph K. Belanoff 2026 Grantor Retained Annuity Trust | 150,000 | $64.98 | $9.7M | 2.7% | Form 4, May 29, 2026 |
Share counts are the amounts Joseph K. Belanoff reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Sold | CORT | 12,837 | $69.74 | $895K | View |
| May 1, 2026 | Sold | CORT | 40,000 | $50.10 | $2.0M | View |
| Mar 25, 2026 | Sold | CORT | 26,198 | $50.07 | $1.3M | View |
| Dec 1, 2025 | Sold | CORT | 40,000 | $79.77 | $3.2M | View |
| Nov 5, 2025 | Sold | CORT | 3,590 | $75.98 | $273K | View |
| Nov 5, 2025 | Sold | CORT | 10,837 | $75.14 | $814K | View |
| Nov 5, 2025 | Sold | CORT | 14,355 | $74.20 | $1.1M | View |
| Nov 3, 2025 | Sold | CORT | 11,218 | $74.08 | $831K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 577 | Thomas William Burns CHAIRMAN & CEO, Glaukos. Aliso Viejo, CA | $369M |
| 578 | Liaw Yih-Shyan Wally Director, Super Micro Computer. San Jose, CA | $369M |
| 579 | Eric Sprott 10% owner, Hycroft Mining Holding | $368M |
| 580 | Joseph K. Belanoff Chief Executive Officer, Corcept Therapeutics. Redwood City, CA | $368M |
| 581 | Toby R. Neugebauer 10% owner, Fermi. Dallas, TX | $368M |
| 582 | Thomas Charles Priore President, CEO and Chairman, Priority Technology Holdings. Alpharetta, GA | $367M |
| 583 | William J.G. Griffith Director, Netskope. San Francisco, CA | $367M |
Other Corcept Therapeutics insiders
All CORT insiders- James N. Wilson$226MDirector. #818 overall
- David L Mahoney$154MDirector. #1077 overall
- G. Leonard Baker Jr.$146MDirector. #1126 overall
- Hazel Hunt$16.6MChief Scientific Officer. #5954 overall
Questions
How much stock does Joseph K. Belanoff own?
Joseph K. Belanoff holds $367,787,645 in listed stock based on SEC filings and current prices, mostly Corcept Therapeutics (CORT). That ranks 580th on the Stock Rich List.
Is this Joseph K. Belanoff's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Joseph K. Belanoff last buy or sell stock?
The most recent open-market trade on file is a sale of 12,837 CORT shares on Jun 1, 2026 at $69.74.